Cargando…
An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma
BACKGROUND: We sought to assess the benefit-risk balance of FOLFIRINOX versus gemcitabine in patients with metastatic pancreatic adenocarcinoma. METHODS: We used generalized pairwise comparisons. This statistical method permits the simultaneous analysis of several prioritized outcome measures. The f...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347744/ https://www.ncbi.nlm.nih.gov/pubmed/27765912 http://dx.doi.org/10.18632/oncotarget.12761 |